NAUT

NAUTILUS BIOTECHNOLOGY, INC.

NAUT · CIK 1808805 · Annual (10-K) · Last 6 years

Financial Trends

Revenue
20202025
Net Income−$59M
20202025
Operating CF−$51M
20202025
Free Cash Flow−$52M
20202025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue
Cost of Revenue
Gross Profit
R&D Expense$0.0B$0.1B$0.0B$0.0B$0.0B
SG&A Expense
Operating Income$-0.0B
Net Income$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B
EPS (Basic)$-0.47$-0.56$-0.51$-0.46$-0.60
EPS (Diluted)$-0.47$-0.56$-0.51$-0.46$-0.60

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Total Assets$0.2B$0.2B$0.3B$0.4B$0.4B$0.2B
Current Assets$0.1B$0.1B$0.2B$0.2B$0.3B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.1B$0.2B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.2B$0.2B$0.3B$0.3B$0.4B$0.0B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.1B$-0.0B$-0.0B$-0.1B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.3B$0.2B